Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancer Letters|May 5, 2015
Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cellsWeilong Yao, Ping Yue, Guojing Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 5, 2024
Coacervation-Driven Semipermeable Nanoreactors for Enzymatic Cascade-Mediated Cancer Combination Therapy with Enhanced EfficacyMin Lin, Xueli Lv, Hepeng Wang, et al.
Colloids and Surfaces. B, Biointerfaces|May 23, 2022
Biomineralization and biotechnological applications of bacterial magnetosomesGaofei Ying, Guojing Zhang, Jiani Yang, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery|October 15, 2021
[In vivo study on the effects of intercellular adhesion operon of Staphylococcus epidermidis on the inflammation associated with bacteria-fungal mixed biofilm]Guojing Zhang, Zilin Wan, Xiaoyan Wang, et al.
Scientific Reports|August 11, 2017
Anthocyanin concentration depends on the counterbalance between its synthesis and degradation in plum fruit at high temperatureJunping Niu, Guojing Zhang, Wenting Zhang, et al.
Tumori|May 24, 2014
Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancerGuojing Zhang, Wanqing Xie, Zhaozhe Liu, et al.
Cancer|June 5, 2020
MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor-mutant lung cancersJiajia Gu, Weilong Yao, Puyu Shi, et al.
Molecular Immunology|April 6, 2019
A tetravalent single chain diabody (CD40/HER2) efficiently inhibits tumor proliferation through recruitment of T cells and anti-HER2 functionsLi Lu, Ningbo Liu, Kaihu Fan, et al.
Archives of Microbiology|May 15, 2016
Halomonas xiaochaidanensis sp. nov., isolated from a salt lake sedimentWen Liu, Guojing Zhang, Wendong Xian, et al.
Lung Cancer (Amsterdam, Netherlands)|October 13, 2020
Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinibJiajia Gu, Luxi Qian, Guojing Zhang, et al.
Pageof 6